CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $65.81M, above the global median of $16.24M
- FinancialsAltman Z-Score -4.51: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
375.56MUSDvs all stocks (USD)
Revenue (TTM)
232.40MUSDvs all stocks (USD)
Profit Margin
-8.83%Beta
0.2350xvs all stocks
52-Week Change
-64.25%vs all stocks
Market Capitalization
375.56MUSDvs all stocks (USD)
Enterprise Value
405.08MUSDvs all stocks (USD)
Forward P/E
-7.37xPrice to Sales (TTM)
1.62xPrice to Book (MRQ)
13.73xEnterprise to Revenue
1.74xEnterprise to EBITDA
33.40xGross Margin
77.05%Profit Margin
-8.83%Operating Margin
-2.76%Return on Assets (TTM)
2.02%Return on Equity (TTM)
-78.95%Revenue (TTM)
232.40MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.8770USDUpdated Jul 17, 2026Quarterly Revenue Growth
-6.60%Gross Profit (TTM)
190.43MUSDvs all stocks (USD)
EBITDA (TTM)
24.83MUSDvs all stocks (USD)
Net Income (TTM)
-20.51MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-6.61%Operating Cash Flow (TTM)
60.37MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
65.81MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 17, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
236.20MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
39.46MUSDFY2025 · Dec 31, 2025Gross Profit
196.73MUSDFY2025 · Dec 31, 2025Operating Income
23.50MUSDvs all stocks (USD)
Pre-tax Income
-3.72MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.62MUSDFY2025 · Dec 31, 2025Net Income
-5.34MUSDFY2025 · Dec 31, 2025EBIT
20.46MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
24.83MUSDFY2025 · Dec 31, 2025Research & Development
62.36MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
107.48MUSDFY2025 · Dec 31, 2025Other Operating Expenses
3.40MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
24.18MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
257.16MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
257.16MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.34MUSDFY2025 · Dec 31, 2025Operating Cash Flow
4.97MUSDFY2025 · Dec 31, 2025Free Cash Flow
4.85MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
186.54MUSDFY2025 · Dec 31, 2025Interest Paid
6.08MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.27MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.28MUSDFY2025 · Dec 31, 2025Other Non-cash Items
37.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-14.14MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.08MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-28.58MUSDFY2025 · Dec 31, 2025Capital Expenditures
-119.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-7.81MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-119.00KUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
10.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-462.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-4.97MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
71.24MUSDFY2025 · Dec 31, 2025Shares Outstanding
267.90MSharesUpdated Jul 17, 2026Float Shares
262.01MSharesUpdated Jul 17, 2026Shares Short
19.18MSharesUpdated Jul 17, 2026Short Ratio
3.10daysvs all stocks
Short % of Shares Outstanding
7.26%vs all stocks
% Held by Insiders
4.06%vs all stocks
% Held by Institutions
42.10%vs all stocks
Total Cash (MRQ)
162.64MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.6060USDUpdated Jul 17, 2026Total Debt (MRQ)
197.52MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
7.22xCurrent Ratio (MRQ)
1.40xBook Value per Share (MRQ)
0.1020USDUpdated Jul 17, 2026Total Assets
376.56MUSDvs all stocks (USD)
Total Current Assets
252.96MUSDFY2025 · Dec 31, 2025Total Liabilities
343.95MUSDFY2025 · Dec 31, 2025Total Non-current Assets
123.61MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
181.02MUSDFY2025 · Dec 31, 2025Total Current Liabilities
162.94MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
184.84MUSDFY2025 · Dec 31, 2025Accounts Receivable
47.03MUSDFY2025 · Dec 31, 2025Inventory
15.61MUSDFY2025 · Dec 31, 2025Accounts Payable
21.18MUSDFY2025 · Dec 31, 2025Short-term Debt
3.55MUSDFY2025 · Dec 31, 2025Deferred Revenue
2.68MUSDFY2025 · Dec 31, 2025Other Current Liabilities
86.52MUSDFY2025 · Dec 31, 2025Long-term Debt
48.25MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
107.18MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.68BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
32.61MUSDvs all stocks (USD)
52-Week Low
0.8230USDUpdated Jul 17, 202652-Week High
4.04USDUpdated Jul 17, 202652-Week Change
-64.25%vs all stocks
Beta
0.2350xvs all stocks
50-Day MA
1.12USDUpdated Jul 17, 2026200-Day MA
1.57USDUpdated Jul 17, 2026Avg 10-Day Volume
4.06MSharesUpdated Jul 17, 2026Avg 30-Day Volume
5.55MSharesUpdated Jul 17, 2026Diluted EPS (TTM)
-0.0800USDUpdated Jul 17, 2026Other Income / Expense
-3.04MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.77Profit Margin: -0.09
Significant cash reserves alongside high leverageNotable
Cash (USD): 162,644,000Total Debt (USD): 197,524,000Debt-to-Equity: 7.22
Financial Health
Altman Z-Score -4.51: distress zoneCritical
Altman Z-Score: -4.51
High structural barrier to entryNotable
Barrier to Entry: 0.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $65.81M, above the global median of $16.24MNotable
Levered free cash flow (USD): 65,809,876Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Rocket Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Cowin Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Compass Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jilin Province Xidian Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Upstream Bio, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Aska Pharmaceutical Holdings Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lexeo Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Huasun Technology Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Larimar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Ecopro BM. Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
KC Tech Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
DK Tech Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated